Animal Health Active Pharmaceutical Ingredients Market Research Report by Business (Captive API and Merchant API), by Indication (Anti-infectives, Antiparasitics, and NSAIDs & Anesthetics), by Synthesis, by Type, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Animal Health Active Pharmaceutical Ingredients Market is expected to grow from USD 13,856.84 Million in 2020 to USD 19,616.72 Million by the end of 2025.
2. The Global Animal Health Active Pharmaceutical Ingredients Market is expected to grow from EUR 12,149.94 Million in 2020 to EUR 17,200.31 Million by the end of 2025.
3. The Global Animal Health Active Pharmaceutical Ingredients Market is expected to grow from GBP 10,801.32 Million in 2020 to GBP 15,291.11 Million by the end of 2025.
4. The Global Animal Health Active Pharmaceutical Ingredients Market is expected to grow from JPY 1,478,875.96 Million in 2020 to JPY 2,093,601.11 Million by the end of 2025.
5. The Global Animal Health Active Pharmaceutical Ingredients Market is expected to grow from AUD 20,121.97 Million in 2020 to AUD 28,486.08 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Animal Health Active Pharmaceutical Ingredients to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Business, the Animal Health Active Pharmaceutical Ingredients Market studied across Captive API and Merchant API.
Based on Indication, the Animal Health Active Pharmaceutical Ingredients Market studied across Anti-infectives, Antiparasitics, and NSAIDs & Anesthetics.
Based on Synthesis, the Animal Health Active Pharmaceutical Ingredients Market studied across Biotech and Synthetic.
Based on Type, the Animal Health Active Pharmaceutical Ingredients Market studied across Branded and Generic.
Based on End User, the Animal Health Active Pharmaceutical Ingredients Market studied across Pet Care Hospitals and Retail and specialty pharmacies.
Based on Geography, the Animal Health Active Pharmaceutical Ingredients Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Animal Health Active Pharmaceutical Ingredients Market including Blanver Farmoquimica E Farmaceutica S.A., Changzhou Yabang-Qh Pharmachem Co., Ltd., Eli Lilly & Co., Excel Industries Ltd., Glenmark Pharmaceutical Ltd., Huvepharma, Indukern, S.A., Lonza Group AG, NGL Fine Chem Ltd., Ningxia Tairui Pharma CO. Ltd., Ofichem BV, Omkar Speciality Chemicals Limited, ouro fino saude animal, P&R SpA (Olon SpA), Sanofi Winthrop Industrie (CEPiA), Sequent Scientific Ltd., Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Shanghai Pharmtech Co. Ltd., Zhejiang Hisun Pharmaceutical Co. Ltd, and Zoetis Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Health Active Pharmaceutical Ingredients Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Animal Health Active Pharmaceutical Ingredients Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Health Active Pharmaceutical Ingredients Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Health Active Pharmaceutical Ingredients Market?
4. What is the competitive strategic window for opportunities in the Global Animal Health Active Pharmaceutical Ingredients Market?
5. What are the technology trends and regulatory frameworks in the Global Animal Health Active Pharmaceutical Ingredients Market?
6. What are the modes and strategic moves considered suitable for entering the Global Animal Health Active Pharmaceutical Ingredients Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Animal Health Active Pharmaceutical Ingredients Market is expected to grow from USD 13,856.84 Million in 2020 to USD 19,616.72 Million by the end of 2025.
2. The Global Animal Health Active Pharmaceutical Ingredients Market is expected to grow from EUR 12,149.94 Million in 2020 to EUR 17,200.31 Million by the end of 2025.
3. The Global Animal Health Active Pharmaceutical Ingredients Market is expected to grow from GBP 10,801.32 Million in 2020 to GBP 15,291.11 Million by the end of 2025.
4. The Global Animal Health Active Pharmaceutical Ingredients Market is expected to grow from JPY 1,478,875.96 Million in 2020 to JPY 2,093,601.11 Million by the end of 2025.
5. The Global Animal Health Active Pharmaceutical Ingredients Market is expected to grow from AUD 20,121.97 Million in 2020 to AUD 28,486.08 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Animal Health Active Pharmaceutical Ingredients to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Business, the Animal Health Active Pharmaceutical Ingredients Market studied across Captive API and Merchant API.
Based on Indication, the Animal Health Active Pharmaceutical Ingredients Market studied across Anti-infectives, Antiparasitics, and NSAIDs & Anesthetics.
Based on Synthesis, the Animal Health Active Pharmaceutical Ingredients Market studied across Biotech and Synthetic.
Based on Type, the Animal Health Active Pharmaceutical Ingredients Market studied across Branded and Generic.
Based on End User, the Animal Health Active Pharmaceutical Ingredients Market studied across Pet Care Hospitals and Retail and specialty pharmacies.
Based on Geography, the Animal Health Active Pharmaceutical Ingredients Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Animal Health Active Pharmaceutical Ingredients Market including Blanver Farmoquimica E Farmaceutica S.A., Changzhou Yabang-Qh Pharmachem Co., Ltd., Eli Lilly & Co., Excel Industries Ltd., Glenmark Pharmaceutical Ltd., Huvepharma, Indukern, S.A., Lonza Group AG, NGL Fine Chem Ltd., Ningxia Tairui Pharma CO. Ltd., Ofichem BV, Omkar Speciality Chemicals Limited, ouro fino saude animal, P&R SpA (Olon SpA), Sanofi Winthrop Industrie (CEPiA), Sequent Scientific Ltd., Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Shanghai Pharmtech Co. Ltd., Zhejiang Hisun Pharmaceutical Co. Ltd, and Zoetis Inc..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Health Active Pharmaceutical Ingredients Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Animal Health Active Pharmaceutical Ingredients Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Animal Health Active Pharmaceutical Ingredients Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Animal Health Active Pharmaceutical Ingredients Market?
4. What is the competitive strategic window for opportunities in the Global Animal Health Active Pharmaceutical Ingredients Market?
5. What are the technology trends and regulatory frameworks in the Global Animal Health Active Pharmaceutical Ingredients Market?
6. What are the modes and strategic moves considered suitable for entering the Global Animal Health Active Pharmaceutical Ingredients Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Synthesis Outlook
3.5. Indication Outlook
3.6. End User Outlook
3.7. Business Outlook
3.8. Geography Outlook
3.9. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising adoption of pets across the globe
5.1.1.2. Increasing awareness and expenditure among people regarding the animal healthcare
5.1.1.3. Significant growth in the number of animal healthcare NGOs
5.1.2. Restraints
5.1.2.1. Several risk factors associated with animal health APIs
5.1.3. Opportunities
5.1.3.1. Development of new products
5.1.3.2. Unmet animal needs in many countries
5.1.4. Challenges
5.1.4.1. Limited awareness and availability in low-income areas
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY BUSINESS
6.1. Introduction
6.2. Captive API
6.3. Merchant API
7. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY INDICATION
7.1. Introduction
7.2. Anti-infectives
7.3. Antiparasitics
7.4. NSAIDs & Anesthetics
8. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY SYNTHESIS
8.1. Introduction
8.2. Biotech
8.3. Synthetic
9. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
9.1. Introduction
9.2. Branded
9.3. Generic
10. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER
10.1. Introduction
10.2. Pet Care Hospitals
10.3. Retail and specialty pharmacies
11. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. South Korea
12.10. Thailand
13. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom
14. COMPETITIVE LANDSCAPE
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis
14.4. Competitor SWOT Analysis
14.5. Competitive Scenario
14.5.1. Merger & Acquisition
14.5.2. Agreement, Collaboration, & Partnership
14.5.3. New Product Launch & Enhancement
14.5.4. Investment & Funding
14.5.5. Award, Recognition, & Expansion
15. COMPANY USABILITY PROFILES
15.1. Blanver Farmoquimica E Farmaceutica S.A.
15.2. Changzhou Yabang-Qh Pharmachem Co., Ltd.
15.3. Eli Lilly & Co.
15.4. Excel Industries Ltd.
15.5. Glenmark Pharmaceutical Ltd.
15.6. Huvepharma
15.7. Indukern, S.A.
15.8. Lonza Group AG
15.9. NGL Fine Chem Ltd.
15.10. Ningxia Tairui Pharma CO. Ltd.
15.11. Ofichem BV
15.12. Omkar Speciality Chemicals Limited
15.13. ouro fino saude animal
15.14. P&R SpA (Olon SpA)
15.15. Sanofi Winthrop Industrie (CEPiA)
15.16. Sequent Scientific Ltd.
15.17. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
15.18. Shanghai Pharmtech Co. Ltd.
15.19. Zhejiang Hisun Pharmaceutical Co. Ltd
15.20. Zoetis Inc.
16. APPENDIX
16.1. Discussion Guide
16.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Type Outlook
3.4. Synthesis Outlook
3.5. Indication Outlook
3.6. End User Outlook
3.7. Business Outlook
3.8. Geography Outlook
3.9. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising adoption of pets across the globe
5.1.1.2. Increasing awareness and expenditure among people regarding the animal healthcare
5.1.1.3. Significant growth in the number of animal healthcare NGOs
5.1.2. Restraints
5.1.2.1. Several risk factors associated with animal health APIs
5.1.3. Opportunities
5.1.3.1. Development of new products
5.1.3.2. Unmet animal needs in many countries
5.1.4. Challenges
5.1.4.1. Limited awareness and availability in low-income areas
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY BUSINESS
6.1. Introduction
6.2. Captive API
6.3. Merchant API
7. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY INDICATION
7.1. Introduction
7.2. Anti-infectives
7.3. Antiparasitics
7.4. NSAIDs & Anesthetics
8. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY SYNTHESIS
8.1. Introduction
8.2. Biotech
8.3. Synthetic
9. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
9.1. Introduction
9.2. Branded
9.3. Generic
10. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER
10.1. Introduction
10.2. Pet Care Hospitals
10.3. Retail and specialty pharmacies
11. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. South Korea
12.10. Thailand
13. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom
14. COMPETITIVE LANDSCAPE
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis
14.4. Competitor SWOT Analysis
14.5. Competitive Scenario
14.5.1. Merger & Acquisition
14.5.2. Agreement, Collaboration, & Partnership
14.5.3. New Product Launch & Enhancement
14.5.4. Investment & Funding
14.5.5. Award, Recognition, & Expansion
15. COMPANY USABILITY PROFILES
15.1. Blanver Farmoquimica E Farmaceutica S.A.
15.2. Changzhou Yabang-Qh Pharmachem Co., Ltd.
15.3. Eli Lilly & Co.
15.4. Excel Industries Ltd.
15.5. Glenmark Pharmaceutical Ltd.
15.6. Huvepharma
15.7. Indukern, S.A.
15.8. Lonza Group AG
15.9. NGL Fine Chem Ltd.
15.10. Ningxia Tairui Pharma CO. Ltd.
15.11. Ofichem BV
15.12. Omkar Speciality Chemicals Limited
15.13. ouro fino saude animal
15.14. P&R SpA (Olon SpA)
15.15. Sanofi Winthrop Industrie (CEPiA)
15.16. Sequent Scientific Ltd.
15.17. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
15.18. Shanghai Pharmtech Co. Ltd.
15.19. Zhejiang Hisun Pharmaceutical Co. Ltd
15.20. Zoetis Inc.
16. APPENDIX
16.1. Discussion Guide
16.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTI-INFECTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTIPARASITICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY NSAIDS & ANESTHETICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BRANDED, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PET CARE HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RETAIL AND SPECIALTY PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 148. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 149. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 150. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 151. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 152. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 153. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 154. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 155. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 156. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 157. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 158. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 159. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 160. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 161. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 162. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 163. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: SCORES
TABLE 164. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: BUSINESS STRATEGY
TABLE 165. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: PRODUCT SATISFACTION
TABLE 166. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: RANKING
TABLE 167. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: MERGER & ACQUISITION
TABLE 168. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 169. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 170. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INVESTMENT & FUNDING
TABLE 171. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 172. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTI-INFECTIVES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTIPARASITICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY NSAIDS & ANESTHETICS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BRANDED, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PET CARE HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RETAIL AND SPECIALTY PHARMACIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 140. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 141. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 142. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 143. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 144. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 145. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 146. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 147. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 148. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 149. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 150. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 151. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 152. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 153. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 154. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 155. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 156. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 157. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 158. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 159. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 160. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 161. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 162. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 163. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: SCORES
TABLE 164. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: BUSINESS STRATEGY
TABLE 165. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: PRODUCT SATISFACTION
TABLE 166. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: RANKING
TABLE 167. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: MERGER & ACQUISITION
TABLE 168. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 169. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 170. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INVESTMENT & FUNDING
TABLE 171. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 172. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2020 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2020 (USD MILLION)
FIGURE 9. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 11. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 12. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 14. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: MARKET DYNAMICS
FIGURE 15. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 16. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2020 VS 2025 (%)
FIGURE 17. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2020 VS 2025 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2025
FIGURE 19. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 22. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2025
FIGURE 24. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTI-INFECTIVES, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTIPARASITICS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY NSAIDS & ANESTHETICS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2020 VS 2025 (%)
FIGURE 28. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2025
FIGURE 30. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 33. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2025
FIGURE 35. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BRANDED, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 38. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUT
FIGURE 1. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 5. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2020 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2020 (USD MILLION)
FIGURE 7. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2020 (USD MILLION)
FIGURE 9. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 11. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 12. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 14. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: MARKET DYNAMICS
FIGURE 15. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 16. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2020 VS 2025 (%)
FIGURE 17. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2020 VS 2025 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2025
FIGURE 19. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE API, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT API, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2020 VS 2025 (%)
FIGURE 22. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2020 VS 2025 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2025
FIGURE 24. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTI-INFECTIVES, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTIPARASITICS, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY NSAIDS & ANESTHETICS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2020 VS 2025 (%)
FIGURE 28. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2025
FIGURE 30. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 33. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2025
FIGURE 35. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BRANDED, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 38. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUT
